SMIH

NASDAQ

Summit Healthcare Acquisition Corp.

SectorFinanceIndustryBlank ChecksIPO2021

$12.27-0.75 (-5.80%)

News25/Ratings0

Summit Healthcare Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Central, Hong Kong.

Latest news

25 items

1130dINSIDER
SEC Form 4 filed by Tan Bo
4 - Summit Healthcare Acquisition Corp. (0001839185) (Issuer)
1130dINSIDER
SEC Form 4 filed by Bai Tao
4 - Summit Healthcare Acquisition Corp. (0001839185) (Issuer)
1130dINSIDER
SEC Form 4 filed by Folinsbee Thomas
4 - Summit Healthcare Acquisition Corp. (0001839185) (Issuer)
1130dINSIDER
SEC Form 4 filed by Summit Healthcare Acquisition Sponsor Llc
4 - Summit Healthcare Acquisition Corp. (0001839185) (Issuer)
1130dINSIDER
SEC Form 4 filed by Poon Cho Fai
4 - Summit Healthcare Acquisition Corp. (0001839185) (Issuer)
1130dINSIDER
SEC Form 4 filed by Stone Ian Charles
4 - Summit Healthcare Acquisition Corp. (0001839185) (Issuer)
1134dSEC
SEC Form 15-12G filed by Summit Healthcare Acquisition Corp.
15-12G - Summit Healthcare Acquisition Corp. (0001839185) (Filer)
1134dSEC
Summit Healthcare Acquisition Corp. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Financial Statements and Exhibits
8-K - Summit Healthcare Acquisition Corp. (0001839185) (Filer)
1134dSEC
SEC Form 25-NSE filed by Summit Healthcare Acquisition Corp.
25-NSE - Summit Healthcare Acquisition Corp. (0001839185) (Subject)
1136dNEWS
Why American Public Education Shares Are Trading Lower By Around 49%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers ThermoGenesis Holdings, Inc. (NASDAQ:THMO) shares jumped 80% to $3.7820 after the company announced the roll out of ReadyStart cGMP Suites for early-stage cell and gene-therapy companies. Loyalty Ventures Inc. (NASDAQ:LYLT) rose 80% to $0.3060 after dipping 23% on Tuesday. Jounce Therapeutics, Inc. (NASDAQ:JNCE) shares climbed 48% to $1.5686 after the company confirmed receipt of unsolicited proposal from Concentra Biosciences to acquire 100% of the company. Elevation Oncology, Inc. (NASDAQ:ELEV) rose 38.1% to $1.9750 after jumping around 29% on Tuesday. Ambipar Emergency Response (NYSE:AMBI) gained 37.8% to $16.88 after jumping around 117% on Tuesday. TC Biopharm (Holdings)
1136dSEC
Summit Healthcare Acquisition Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
8-K - Summit Healthcare Acquisition Corp. (0001839185) (Filer)
1136dPR
YS BIOPHARMA AND SUMMIT HEALTHCARE ANNOUNCE SHAREHOLDER APPROVAL OF BUSINESS COMBINATION
Business Combination to deliver approximately $36 million of gross proceeds YS Biopharma expects to close the Business Combination on March 16, 2023YS Biopharma Ordinary Shares and YS Biopharma Warrants expected to begin trading on the Nasdaq on March 17, 2023 under the symbols "YS" and "YSBPW," respectivelyNEW YORK, March 14, 2023 /PRNewswire/ -- YishengBio Co., Ltd (to be renamed as YS Biopharma Co., Ltd., and herein referred to as "YS Biopharma"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer, and Summit Healthcare Acquisition Corp. (NASDAQ:
1158dSEC
SEC Form DEFA14A filed by Summit Healthcare Acquisition Corp.
DEFA14A - Summit Healthcare Acquisition Corp. (0001839185) (Filer)
1158dSEC
Summit Healthcare Acquisition Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
8-K - Summit Healthcare Acquisition Corp. (0001839185) (Filer)
1164d13D/G
SEC Form SC 13G filed by Summit Healthcare Acquisition Corp.
SC 13G - Summit Healthcare Acquisition Corp. (0001839185) (Subject)
1166d13D/G
SEC Form SC 13G filed by Summit Healthcare Acquisition Corp.
SC 13G - Summit Healthcare Acquisition Corp. (0001839185) (Subject)
1171dPR
SUMMIT HEALTHCARE ACQUISITION CORP. AND YS BIOPHARMA ANNOUNCE EFFECTIVENESS OF REGISTRATION STATEMENT AND EXTRAORDINARY GENERAL MEETING DATE FOR PROPOSED BUSINESS COMBINATION
Extraordinary general meeting of Summit Healthcare Acquisition Corp.'s shareholders to be held on March 1, 2023 at 9:00 a.m. Eastern Time YS Biopharma is a global biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancerYS Biopharma achieved vaccine sales of RMB400 million for the first half of the fiscal year 2023, 48% higher than the same period of the prior fiscal yearCombined company to be listed on Nasdaq under ticker "YS"NEW YORK, Feb. 8, 2023 /PRNewswire/ -- Summit Healthcare Acquisition Corp. ("Summit") (NASDAQ:SMIH), a special purpose acquisition company,
1171dSEC
SEC Form DEFM14A filed by Summit Healthcare Acquisition Corp.
DEFM14A - Summit Healthcare Acquisition Corp. (0001839185) (Filer)
1171dSEC
Summit Healthcare Acquisition Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
8-K - Summit Healthcare Acquisition Corp. (0001839185) (Filer)
1176d13D/G
SEC Form SC 13G/A filed by Summit Healthcare Acquisition Corp. (Amendment)
SC 13G/A - Summit Healthcare Acquisition Corp. (0001839185) (Subject)
1179d13D/G
SEC Form SC 13G/A filed by Summit Healthcare Acquisition Corp. (Amendment)
SC 13G/A - Summit Healthcare Acquisition Corp. (0001839185) (Subject)
1192dSEC
Summit Healthcare Acquisition Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
8-K - Summit Healthcare Acquisition Corp. (0001839185) (Filer)
1256dSEC
SEC Form 10-Q filed by Summit Healthcare Acquisition Corp.
10-Q - Summit Healthcare Acquisition Corp. (0001839185) (Filer)
1302dNEWS
Summit Healthcare Acquisition Shares Resume Trade Following News Pending Halt
1302dSEC
SEC Form 425 filed by Summit Healthcare Acquisition Corp.
425 - Summit Healthcare Acquisition Corp. (0001839185) (Subject)